Aigen Investment Management’s Ascendis Pharma A/S ASND Stock Holding History

Aigen Investment Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	4,073 +2,532	+164%	+$591K	0.3%	95
2026 Q1	$352K	Buy	1,541 +357	+30%	+$80K	0.09%	291
2025 Q4	$252K	Buy	+1,184	New	+$245K	0.06%	404
2025 Q3	–	Sell	-1,475	Closed	-$255K	–	785
2025 Q2	$255K	Buy	1,475 +12	+0.8%	+$1.96K	0.03%	584
2025 Q1	$228K	Sell	1,463 -869	-37%	-$124K	0.04%	593
2024 Q4	$321K	Buy	2,332 +666	+40%	+$87.6K	0.06%	456
2024 Q3	$249K	Sell	1,666 -1,491	-47%	-$201K	0.05%	518
2024 Q2	$431K	Sell	3,157 -2,753	-47%	-$375K	0.08%	355
2024 Q1	$893K	Buy	+5,910	New	+$843K	0.19%	161

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Aigen Investment Management's ASND Position: Q2 2026 in Review

Aigen Investment Management increased its Ascendis Pharma A/S (ASND) stake by 164% in Q2 2026, buying an estimated $591K and bringing the position to 4,073 shares worth $1.09M. The position accounts for 0.3% of the portfolio, ranked #95.

Aigen Investment Management first reported a position in ASND in Q1 2024 and has held it in 9 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Aigen Investment Management held 4,073 shares of Ascendis Pharma A/S worth $1.09M as of Q2 2026.
Aigen Investment Management bought 2,532 Ascendis Pharma A/S shares in Q2 2026, an estimated $591K.
Ascendis Pharma A/S made up 0.3% of Aigen Investment Management's portfolio in Q2 2026, its #95 holding.
Aigen Investment Management first reported a position in Ascendis Pharma A/S in Q1 2024 and has held it in 9 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.